Inhibrx Biosciences, Inc. (INBX)
NASDAQ · Healthcare
Inhibrx Biosciences, Inc. Long Term Debt 2023–2025
Inhibrx Biosciences, Inc. annual long term debt history from 2023 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Inhibrx Biosciences, Inc. long term debt as of December 31, 2025: 100.6M, a 51.41% decrease year-over-year.
- Inhibrx Biosciences, Inc. long term debt for 2025 were 100.6M, a 51.41% decrease from 2023.
- Inhibrx Biosciences, Inc. long term debt for 2023 were 207.0M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Inhibrx Biosciences, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $101 |
| 2023 | $207 |
Inhibrx Biosciences, Inc. Long Term Debt — FAQ
Inhibrx Biosciences, Inc. (INBX) long term debt over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see INBX's long term debt history?
The chart and table above show Inhibrx Biosciences, Inc.'s long term debt by year and by quarter, including the growth rate.